SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-14-001240
Filing Date
2014-03-11
Accepted
2014-03-11 16:30:44
Documents
11
Period of Report
2014-01-31

Document Format Files

Seq Description Document Type Size
1 c76749_10q.htm 10-Q 730177
2 c76749_ex31-1.htm EX-31.1 9800
3 c76749_ex31-2.htm EX-31.2 9617
4 c76749_ex32-1.htm EX-32.1 4095
5 c76749_ex32-2.htm EX-32.2 4108
  Complete submission text file 0000930413-14-001240.txt   6460205

Data Files

Seq Description Document Type Size
6 enz-20140131.xml EX-101.INS 1176116
7 enz-20140131.xsd EX-101.SCH 50926
8 enz-20140131_cal.xml EX-101.CAL 35277
9 enz-20140131_def.xml EX-101.DEF 214664
10 enz-20140131_lab.xml EX-101.LAB 361223
11 enz-20140131_pre.xml EX-101.PRE 224092
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 14684591
SIC: 8071 Services-Medical Laboratories